Data from the Centers for Disease Control and Prevention (CDC) in 2023 indicates that adult obesity rates have risen sharply, with 23 states now reporting rates above 35%. Obesity is linked to many serious health risks, such as stroke, heart disease, and diabetes. For many, sticking to strict diets or exercise routines is challenging, making weight loss a difficult journey. As a result, more people are turning to medical treatments for support in managing their weight.
Recently, the FDA approved new injectable medications, such as Zepbound and Wegovy, to support weight management. These options are gaining traction as alternatives to traditional weight loss programs.
This article will compare Zepbound vs Wegovy in terms of efficacy, dosage, and specific uses to help patients choose which treatment best suits their needs.
What’s the difference between Wegovy and Zepbound?
| Parameters | Zepbound | Wegovy |
|---|---|---|
| Cost | $1,059.87/per package | $1,349.02/per package |
| Active Ingredient | Tirzepatide | Semaglutide |
| Approved Indications | Chronic weight management for overweight or obese adults. | Chronic weight management for overweight or obese individuals aged 12 and older, and reduction of MACE risk in adults with heart disease who are overweight or obese. |
| Route of Administration | Subcutaneous injection | Subcutaneous injection |
| Side Effects |
Nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, burping, hair loss, gastroesophageal reflux disease. |
Nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, burping, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis. |
| Dosage and Administration | Initial dosage is 2.5 mg per week, with a maximum dose of 15 mg per week. | Initial dosage is 0.25 mg per week, with a maximum dose of 2.4 mg per week. |
Zepbound vs. Wegovy Efficacy
In a 2024 study comparing Zepbound vs Wegovy for weight management, participants taking Zepbound were more likely to see significant weight loss in just three months. Below are the results:
| Time Frame | Zepbound Weight Loss Percentage | Wegovy Weight Loss Percentage |
|---|---|---|
| 3 Months | 5.9 | 3.6 |
| 6 Months | 10.1 | 5.8 |
| 12 Months | 15.3 | 8.3 |
In addition, this study aligns with previous research showing that Zepbound and Wegovy help people with obesity or overweight lose weight. In studies comparing these drugs to placebos (inactive treatments), taking Zepbound at 10 mg per week led to at least 5% weight loss in 82% of those with type 2 diabetes (T2D) and 96% without T2D after 72 weeks.
Similarly, Wegovy at 2.4 mg per week achieved this same weight loss for 73% of participants with T2D and 92% without T2D after 68 weeks. Though direct comparisons are limited, one study showed that Zepbound (5 mg per week) outperformed Wegovy (1 mg per week) for weight loss among people with T2D.
Zepbound vs. Wegovy Side Effects
The common and serious side effects of Zepbound and Wegovy are shown in the table below:
| Side Effect | Zepbound | Wegovy |
|---|---|---|
| Common Side Effects | ||
| Nausea | ||
| Diarrhea | ||
| Vomiting | ||
| Constipation | ||
| Abdominal pain | ||
| Fatigue | ||
| Dyspepsia (indigestion) | ||
| Burping | ||
| Hair loss | ||
| Gastroesophageal reflux disease | ||
| Dizziness | ||
| Abdominal distension | ||
| Hypoglycemia (in patients with type 2 diabetes) | ||
| Flatulence | ||
| Headache | ||
| Nasopharyngitis | ||
| Gastroenteritis | ||
| Serious Side Effects | ||
| Acute pancreatitis | ||
| Acute gallbladder disease | ||
| Hypoglycemia | ||
| Acute kidney injury | ||
| Hypersensitivity reactions | ||
| Suicidal behavior and ideation | ||
| Diabetic retinopathy complications | ||
| Severe gastrointestinal adverse reactions | ||
| Risk of pulmonary aspiration during general anesthesia | ||
| Increased heart rate |
Pro Tip
To minimize side effects of GLP-1 drugs like Zepbound and Wegovy, experts recommend eating smaller, more frequent meals and stopping before you feel full. Avoid foods and drinks that can trigger gastrointestinal symptoms, such as high-fat and spicy foods, alcohol, and carbonated beverages.
Zepbound vs. Wegovy Mechanism of Action
Zepbound and Wegovy work by mimicking GLP-1 (glucagon-like peptide-1), a gut hormone that regulates appetite and blood sugar. This hormone helps lower appetite, increase feelings of fullness, and reduce cravings. It also slows digestion and delays stomach emptying.
However, Zepbound goes a step further by mimicking another hormone called GIP (glucose-dependent insulinotropic polypeptide). This hormone enhances the appetite-reducing effects of GLP-1, potentially improving weight management. As a dual-action drug, Zepbound may offer more significant weight loss benefits compared to Wegovy.
Approved Indications of Zepbound vs. Wegovy
Both Zepbound and Wegovy are indicated for chronic weight management in adults. They are specifically aimed at individuals who are obese, meaning those with a body mass index (BMI) of 30 kg/m² or greater. Overweight adults with a BMI of 27 kg/m² or greater may also qualify if they have at least one weight-related health condition, such as hypertension or type 2 diabetes.
Wegovy is also approved for chronic weight management in patients aged 12 and older who are classified as obese based on BMI. It is also recommended for adults with heart disease who are overweight or obese, as it can lower the risk of major cardiac problems like heart attacks, strokes, and heart failure.
These drugs are recommended to be used in combination with a reduced-calorie diet and increased physical activity. Both are intended for long-term use to support weight reduction and maintenance.
Zepbound vs Wegovy Contraindications
Zepbound and Wegovy have specific contraindications to consider before use, such as:
-
- Personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2).
- Pregnant or planning to become pregnant.
- Individuals with a severe allergic reaction to semaglutide should avoid Wegovy, while those allergic to tirzepatide should avoid Zepbound.
- History of suicide or suicidal ideation.
Zepbound vs Wegovy Dosing
Both Zepbound and Wegovy are administered through subcutaneous injection in the abdomen, thigh, or upper arm. They can be taken with or without food, and the dosage increases every four weeks.
Here’s a chart to compare the dosing schedules for Zepbound and Wegovy:
| Medication | Starting Dose | Titration Dose | Maximum Dose | ||||
| Month 1 | Month 2 | Month 3 | Month 4 | Month 5+ | |||
| Wegovy | 0.25 mg once weekly | 0.25 mg per week | 0.5 mg per week | 0.5-1.0 mg per week | 1.0-1.7 mg per week | 1.7-2.4 mg per week | 2.4 mg once weekly |
| Zepbound | 2.5 mg once weekly | 2.5 mg per week | 5.0 mg per week | 5.0-7.5 mg per week | 7.5-10 mg per week | 10-12.5 mg per week | 15 mg once weekly |
Final Thoughts
Zepbound vs Wegovy have different advantages for weight management. Zepbound demonstrates greater efficacy, with research participants experiencing more significant weight loss over three months than those using Wegovy. While both medications share common side effects like nausea and diarrhea, Zepbound is associated with a broader range of side effects.
In terms of cost, Wegovy is more expensive based on their list prices. Finally, patients should consult a healthcare provider for proper guidance. Individual health status and medical history will influence the choice of medication.
Zepbound vs Wegovy Cost
In the US, Zepbound has a list price of $1,059.87 for a box of four pre-filled pens. On the other hand, Wegovy’s list price is $1,349.02 for a box of four pens. Both medications are brand-name drugs and do not have generic alternatives, which can make them expensive. The total cost may vary depending on insurance coverage and pharmacy pricing.
For a more affordable option, consider purchasing from trusted online pharmacy partners in Canada, like Pharma Giant, which ships directly to the US. While Zepbound is currently unavailable, Wegovy sells for just $609.99.
Related Articles
